Comparative efficacy and safety of radiotherapy/cetuximab versus radiotherapy/chemotherapy for locally advanced head and neck squamous cell carcinoma patients: a systematic review of published, primarily non-randomized, data

BACKGROUND: Cetuximab (CTX) has been approved to be administered concurrently with radiotherapy (RT) to treat locally advanced head and neck squamous cell carcinoma (HNSCC). The aim of this study was to assess the efficacy and safety of concurrent CTX with RT (ExRT). METHOD: The PubMed, Cochrane Lib...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Mei, Chen, Yu-Huan, Meng, Tian, Qu, Ling-Han, Zhang, Zhi-Yong, Zhang, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727048/
https://www.ncbi.nlm.nih.gov/pubmed/33343720
http://dx.doi.org/10.1177/1758835920975355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727048/
https://www.ncbi.nlm.nih.gov/pubmed/33343720
http://dx.doi.org/10.1177/1758835920975355

Ejemplares similares